17-66226018-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000205948.11(APOH):c.338+10T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,598,472 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0058 ( 8 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 11 hom. )
Consequence
APOH
ENST00000205948.11 intron
ENST00000205948.11 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.802
Genes affected
APOH (HGNC:616): (apolipoprotein H) Apolipoprotein H, also known as beta-2-glycoprotein I, is a component of circulating plasma lipoproteins. It has been implicated in a variety of physiologic pathways including lipoprotein metabolism, coagulation, hemostasis, and the production of antiphospholipid autoantibodies. APOH may be a required cofactor for anionic phospholipid binding by the antiphospholipid autoantibodies found in sera of many patients with lupus and primary antiphospholipid syndrome (APS). The anti-beta (2) glycoprotein I antibodies from APS patients, mediate inhibition of activated protein C which has anticoagulant properties. Because beta-2-GPI is the main autoantigen in patients with APS, the disruption of this pathway by autoantibodies may be an important mechanism for thrombosis in patients with APS.[provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-66226018-A-C is Benign according to our data. Variant chr17-66226018-A-C is described in ClinVar as [Benign]. Clinvar id is 780448.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00585 (891/152314) while in subpopulation AFR AF= 0.0206 (857/41576). AF 95% confidence interval is 0.0195. There are 8 homozygotes in gnomad4. There are 409 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOH | NM_000042.3 | c.338+10T>G | intron_variant | ENST00000205948.11 | NP_000033.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOH | ENST00000205948.11 | c.338+10T>G | intron_variant | 1 | NM_000042.3 | ENSP00000205948 | P1 | |||
APOH | ENST00000577982.1 | c.338+10T>G | intron_variant | 5 | ENSP00000464301 | |||||
APOH | ENST00000581797.5 | c.158+10T>G | intron_variant | 3 | ENSP00000463553 |
Frequencies
GnomAD3 genomes AF: 0.00584 AC: 889AN: 152196Hom.: 8 Cov.: 33
GnomAD3 genomes
AF:
AC:
889
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00154 AC: 384AN: 249378Hom.: 1 AF XY: 0.00110 AC XY: 148AN XY: 134732
GnomAD3 exomes
AF:
AC:
384
AN:
249378
Hom.:
AF XY:
AC XY:
148
AN XY:
134732
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000573 AC: 828AN: 1446158Hom.: 11 Cov.: 28 AF XY: 0.000450 AC XY: 324AN XY: 720256
GnomAD4 exome
AF:
AC:
828
AN:
1446158
Hom.:
Cov.:
28
AF XY:
AC XY:
324
AN XY:
720256
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00585 AC: 891AN: 152314Hom.: 8 Cov.: 33 AF XY: 0.00549 AC XY: 409AN XY: 74476
GnomAD4 genome
AF:
AC:
891
AN:
152314
Hom.:
Cov.:
33
AF XY:
AC XY:
409
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at